MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 13.11.2025
Land |
 Vereinigte Staaten |
IPO-Jahr |
2017 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
39.4 M |
Marktkapitalisierung |
$ 4.3 B |
EBITDA (LTM) |
$ -81.5 M |
P/E (LTM) |
-31.28 |
P/S (LTM) |
- |
EPS (LTM) |
-3.52 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Anixa Biosciences
ANIX
|
$ 2.87 | -3.04 % | $ 93.1 K | Nasdaq Capital Market | USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Agilent Technologies
A
|
$ 118.59 | 0.39 % | $ 36.1 B | NYSE,SPB | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Castle Biosciences
CSTL
|
$ 27.69 | -1.07 % | $ 769 M | Nasdaq Global Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Charles River Laboratories International
CRL
|
$ 175.98 | -1.49 % | $ 8.72 B | NYSE,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Fulgent Genetics
FLGT
|
$ 13.9 | -2.11 % | $ 420 M | Nasdaq Global Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
|
Biodesix
BDSX
|
$ 16.01 | 1.62 % | $ 2.08 B | Nasdaq Global Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
BioNano Genomics
BNGO
|
$ 1.11 | -2.63 % | $ 1.41 M | Nasdaq Capital Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 209.65 | -0.29 % | $ 23.3 B | NYSE,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 203.85 | -0.99 % | $ 145 B | NYSE,SPB | USA |
 |
Exact Sciences Corporation
EXAS
|
$ 103.36 | 0.01 % | $ 19.5 B | Nasdaq Capital Market,SPB | USA |
 |
Bioventus
BVS
|
$ 8.85 | 0.91 % | $ 554 M | Nasdaq Global Select Market | USA |
 |
DarioHealth Corp.
DRIO
|
$ 10.3 | -4.19 % | $ 292 M | Nasdaq Capital Market |  Israel |
 |
DexCom
DXCM
|
$ 73.26 | -0.7 % | $ 28.6 B | Nasdaq Global Select Market,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
Burning Rock Biotech Limited
BNR
|
$ 24.01 | -4.59 % | $ 254 M | Nasdaq Global Market | China |
 |
VolitionRx Limited
VNRX
|
$ 0.2 | -2.17 % | $ 19.2 M | NYSE American |  Singapore |
 |
CareDx, Inc
CDNA
|
$ 18.74 | -0.03 % | $ 999 M | Nasdaq Global Market,SPB | USA |
 |
ICON Public Limited Company
ICLR
|
$ 108.07 | -0.18 % | $ 8.91 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
$ 639.3 | 0.41 % | $ 51.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Illumina
ILMN
|
$ 130.84 | -1.54 % | $ 20.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
Guardant Health
GH
|
$ 94.83 | 2.82 % | $ 11.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 283.93 | -0.81 % | $ 23.6 B | NYSE,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 79.25 | 3.87 % | $ 5.35 B | Nasdaq Global Select Market,SPB | USA |
 |
IQVIA Holdings
IQV
|
$ 174.04 | -0.14 % | $ 29.9 B | NYSE,SPB | USA |
 |
Brainsway Ltd.
BWAY
|
$ 23.08 | -2.57 % | $ 99.4 M | Nasdaq Global Select Market | Israel |
 |
Co-Diagnostics
CODX
|
- | - | $ 79.8 M | Nasdaq Capital Market | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 317.21 | -0.44 % | $ 27.1 B | NYSE,SPB |  Schweiz |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Myriad Genetics
MYGN
|
$ 5.32 | 6.19 % | $ 493 M | Nasdaq Global Select Market,SPB | USA |
 |
NeoGenomics
NEO
|
$ 9.71 | 2.21 % | $ 1.24 B | Nasdaq Global Select Market,SPB | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Natera
NTRA
|
$ 209.59 | 4.71 % | $ 20.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Pacific Biosciences of California
PACB
|
$ 1.55 | -4.63 % | $ 465 M | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 11.01 | -1.26 % | $ 2.39 B | Nasdaq Global Select Market,SPB | USA |
 |
Precipio
PRPO
|
$ 24.7 | 0.08 % | $ 32.1 M | Nasdaq Global Select Market | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |